# Validation of Macimorelin as a Test for Adult Growth Hormone Deficiency

> **NCT02558829** · PHASE3 · COMPLETED · sponsor: **AEterna Zentaris** · enrollment: 157 (actual)

## Conditions studied

- Growth Hormone Deficiency With Pituitary Anomalies

## Interventions

- **DRUG:** Macimorelin
- **DRUG:** Insulin

## Key facts

- **NCT ID:** NCT02558829
- **Lead sponsor:** AEterna Zentaris
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12-03
- **Primary completion:** 2016-11-29
- **Final completion:** 2016-11-29
- **Target enrollment:** 157 (ACTUAL)
- **Last updated:** 2018-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02558829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02558829, "Validation of Macimorelin as a Test for Adult Growth Hormone Deficiency". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02558829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*